TheStreet

Log In

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?Don't have an account? Sign Up Here

Join Us

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Already have an account? Login here
TheStreet
JIM CRAMERINVESTINGPERSONAL FINANCERETIREMENTTECHNOLOGYMARKETSHOW-TOVIDEOFINANCIAL ADVISOR CENTER
Search

Trade with Jim Cramer 14 Days Free

Join the Action Alerts PLUS Community today!

SUBSCRIBE NOW

LATEST NEWS

FDA deals blow to Endo over Opana ER Pain Med
MARKETS

One Reason Why Catalyst Pharmaceuticals (CPRX) Stock Is Jumping Today

  • By Kaya Yurieff
  • Oct 5, 2016 12:25 PM EDT
PRESS RELEASES

Catalyst Pharmaceuticals To Hold Third Quarter 2020 Financial Results And Corporate Update Conference Call And Webcast On Tuesday, November 10th, 2020

  • By GlobeNewswire
  • Nov 2, 2020 8:03 AM EST
PRESS RELEASES

Catalyst Pharmaceuticals Announces Filing Of Patent Infringement Actions Against Jacobus Pharmaceuticals And PantherRx

  • By GlobeNewswire
  • Oct 19, 2020 6:03 AM EDT
PRESS RELEASES

Catalyst Pharmaceuticals Announces Issuance Of U.S. Patent For Firdapse®

  • By GlobeNewswire
  • Oct 6, 2020 11:15 AM EDT
PRESS RELEASES

Catalyst Pharmaceuticals Announces Ruling On Lawsuit Against The FDA And Intent To Appeal

  • By GlobeNewswire
  • Sep 29, 2020 4:40 PM EDT
PRESS RELEASES

KYE Pharmaceuticals And Catalyst Pharmaceuticals Challenge Health Canada's Decision To Overlook Firdapse® Data Exclusivity

  • By GlobeNewswire
  • Aug 26, 2020 9:40 AM EDT
PRESS RELEASES

Catalyst Pharmaceuticals Announces Notice Of Allowance Of A U.S. Patent Application For "Methods Of Administering 3,4-Diaminopyridine"

  • By GlobeNewswire
  • Aug 11, 2020 6:00 AM EDT
PRESS RELEASES

Catalyst Pharmaceuticals To Hold Second Quarter 2020 Financial Results And Corporate Update Conference Call And Webcast On Tuesday, August 11th, 2020

  • By GlobeNewswire
  • Aug 3, 2020 8:03 AM EDT
PRESS RELEASES

Catalyst Pharmaceuticals Comments On Magistrate Judge's Report And Recommendation In Its Lawsuit Against The FDA

  • By GlobeNewswire
  • Jul 31, 2020 11:10 AM EDT
PRESS RELEASES

Catalyst Pharmaceuticals Appoints Jeffrey Del Carmen As Chief Commercial Officer

  • By GlobeNewswire
  • Jun 23, 2020 8:03 AM EDT
PRESS RELEASES

Catalyst Pharmaceuticals To Present At The Jefferies Virtual Healthcare Conference

  • By GlobeNewswire
  • Jun 1, 2020 8:03 AM EDT
PRESS RELEASES

Catalyst Pharmaceuticals To Hold First Quarter 2020 Financial Results And Corporate Update Conference Call And Webcast On Tuesday, May 12th, 2020

  • By GlobeNewswire
  • May 4, 2020 8:03 AM EDT
PRESS RELEASES

Catalyst Pharmaceuticals Provides Update On Impact Of COVID-19 Pandemic On Its Business Activities

  • By GlobeNewswire
  • Apr 8, 2020 6:00 AM EDT
PRESS RELEASES

Catalyst Pharmaceuticals To Hold Fourth Quarter And Year-End Financial Results And Corporate Update Conference Call And Webcast On Tuesday, March 17th, 2020

  • By GlobeNewswire
  • Mar 10, 2020 8:03 AM EDT
PRESS RELEASES

Catalyst Pharmaceuticals Announces Support Of Rare Disease Day 2020

  • By GlobeNewswire
  • Feb 27, 2020 8:03 AM EST
PRESS RELEASES

Catalyst Pharmaceuticals To Present At The Cowen 40th Annual Health Care Conference

  • By GlobeNewswire
  • Feb 26, 2020 8:03 AM EST
PRESS RELEASES

Catalyst Pharmaceuticals To Present At The 22nd Annual BIO CEO & Investor Conference

  • By GlobeNewswire
  • Feb 6, 2020 8:03 AM EST
FDA deals blow to Endo over Opana ER Pain Med
MARKETS

One Reason Why Catalyst Pharmaceuticals (CPRX) Stock Is Jumping Today

  • By Kaya Yurieff
  • Oct 5, 2016 12:25 PM EDT
Will Whiting Petroleum (WLL) Stock Be Hurt by Goldman Downgrade?
STOCKS

These 7 stocks under $10 could make you a lot of money. Here's how to trade them from here.

  • By Roberto Pedone
  • Aug 19, 2016 7:57 AM EDT
PTC Therapeutics Duchenne Drug Stuck on Conditional Approval Status in Europe
STOCKS

Anavex Plays the Orphan Drug Stock Promotion Game

  • By Adam Feuerstein
  • Apr 12, 2016 7:00 AM EDT
Univar to Buy Nexeo for $2 Billion
MARKETS

Catalyst Pharmaceuticals (CPRX) Stock Plunges After FDA 'Refusal to File' Letter

  • By Amanda Albright
  • Feb 17, 2016 2:50 PM EST
NewLink Pancreatic Cancer Vaccine Fails, May Even Harm Patients
STOCKS

Catalyst Pharma plummets on FDA 'refuse-to-file' letter

  • By Adam Feuerstein
  • Feb 17, 2016 8:20 AM EST
Amicus Shares Barely Budge on Prediction of $3 Billion Buyout
STOCKS

Doctors, Patients Battling Sky-High Drug Price Increase

  • By Adam Feuerstein
  • Oct 29, 2015 6:20 AM EDT
PTC Therapeutics (PTCT) Stock Upgraded at Jefferies
OPINION

4 Breakout Biotech Stocks Under $10 to Watch

  • By Roberto Pedone
  • Jun 18, 2015 2:36 PM EDT
Biotech Stock Mailbag: Biogen's Alzheimer's Update, Celgene Patent Worries, Receptos, MannKind
STOCKS

Catalyst Pharma Competitor Surprises With Positive Orphan Disease Drug Study Results

  • By Adam Feuerstein
  • Apr 24, 2015 12:05 PM EDT
TheStreet
  • Terms Of Use
  • Privacy Policy
  • Advertise
  • Reprints
  • Customer Service
  • Data
  • Topic Archive
  • Subscriptions
© 2021 TheStreet, Inc. All rights reserved. Action Alerts PLUS is a registered trademark of TheStreet, Inc.